Carregant...
Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
A number of trials have studied the value of aromatase inhibitors (AIs) for the adjuvant treatment of early hormone-responsive postmenopausal breast cancer. Three different AIs have been used and they have been compared as initial treatment (two trials) or after 2–3 years of tamoxifen (four trials),...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361185/ https://ncbi.nlm.nih.gov/pubmed/16434989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602964 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|